FDA approvals

Another medium molecule hits the market
Agosto 8, 2019

Bremelanotide (commercialized as Vyleesi) has recently been approved by the FDA for the treatment of low sexual desire in women.

Ler máis
Review of the Month: Opportunities with Macrocycles
Xuño 26, 2019

The macrocycles provides access to new chemical space and opportunities in drug discovery that are otherwise difficult to reach with small molecules.

Ler máis
Lorcaserin approved
Xuño 29, 2012

Well, it is the first anti-obesity drug approved by the FDA in 13 years (last one was Roche’s Orlistat, marketed as Xenical…

Ler máis